Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
New strategy found to delay onset of blindness in mice

New strategy found to delay onset of blindness in mice

Immune cells can repopulate in the retina after elimination, mice study shows

Immune cells can repopulate in the retina after elimination, mice study shows

Duke scientists pinpoint new therapeutic target for macular degeneration

Duke scientists pinpoint new therapeutic target for macular degeneration

BIST researchers develop new retinal prosthesis to address visual degeneration

BIST researchers develop new retinal prosthesis to address visual degeneration

Study finds genetic treatment for inherited retinal disorder

Study finds genetic treatment for inherited retinal disorder

New gene therapy for blindness may soon be reality

New gene therapy for blindness may soon be reality

FDA advisory committee vote 16-0 for first even gene therapy for rare blindness

FDA advisory committee vote 16-0 for first even gene therapy for rare blindness

Study reveals how changes in gene can lead to blindness in middle age

Study reveals how changes in gene can lead to blindness in middle age

Second Sight achieves milestone with conditional FDA approval to start Orion feasibility clinical trial

Second Sight achieves milestone with conditional FDA approval to start Orion feasibility clinical trial

Bionic vision restoration: could future technologies restore sight?

Bionic vision restoration: could future technologies restore sight?

Research shows how dietary essential fatty acids can help treat Alzheimer’s, other diseases

Research shows how dietary essential fatty acids can help treat Alzheimer’s, other diseases

Immune system controls eye tissue regeneration in zebrafish, research finds

Immune system controls eye tissue regeneration in zebrafish, research finds

Study finds link between gene mutation and retinitis pigmentosa in U.S. Hispanic families

Study finds link between gene mutation and retinitis pigmentosa in U.S. Hispanic families

Sperm epigenetics and fertility

Sperm epigenetics and fertility

New synthetic retina could offer new hope to visually impaired people

New synthetic retina could offer new hope to visually impaired people

Powerful pain medicine may help reduce vision damage of glaucoma

Powerful pain medicine may help reduce vision damage of glaucoma

Researchers use gene-editing tool to restore visual function in mouse models of retinitis pigmentosa

Researchers use gene-editing tool to restore visual function in mouse models of retinitis pigmentosa

Researchers reveal promising performance of retinal prosthesis implanted in rats

Researchers reveal promising performance of retinal prosthesis implanted in rats

Light can be used to control cellular functions, optogenetics study shows

Light can be used to control cellular functions, optogenetics study shows

CIRM funds clinical study to test safety, efficacy of new retinitis pigmentosa treatment

CIRM funds clinical study to test safety, efficacy of new retinitis pigmentosa treatment